BIRD-C Competitors and Similar CompaniesClear all
Camel-IDS's competitors and similar companies include Indapta Therapeutics.
 Camel-IDS Camel-IDS is a biotech company developing targeted radionuclide therapeutic solutions against cancer. |  Indapta Therapeutics Indapta Therapeutics is a biotechnology company, which is focused on developing and a proprietary, off-the-shelf, allogeneic FcRγ-deficient natural killer (G-NK) cell therapy to treat multiple types of cancer. | |
Founding Date | Founding Date 2014 | Founding Date 2017 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Brussel, BE HQ | Locations HQ |
Employees | Employees 36 | Employees 8 |
Funding | ||
Latest funding round | Latest funding round $ 41.7m (over 7 years ago) | Latest funding round $ 50m (over 4 years ago) |
Total funding raised | Total funding raised $ 41.7m | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
Indapta Therapeutics
HQ
Employees
8
Indapta Therapeutics is a biotechnology company, which is focused on developing and a proprietary, off-the-shelf, allogeneic FcRγ-deficient natural killer (G-NK) cell therapy to treat multiple types of cancer.
View company